These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2560821)

  • 1. Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist.
    Alexander GJ; Chatterjie N
    Neurochem Res; 1989 Dec; 14(12):1229-34. PubMed ID: 2560821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone-6-spirohydantoin: a new non-toxic compound with anticonvulsive properties.
    Chatterjie N; Alexander GJ
    Neuropharmacology; 1983 Sep; 22(9):1151-3. PubMed ID: 6633824
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.
    Chatterjie N; Inturrisi CE
    J Med Chem; 1975 May; 18(5):490-2. PubMed ID: 1151958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A spirohydantoin derivative of oxymorphone: an agonist with delayed antagonist activity.
    Alexander GJ; Chatterjie N; Wisniewski HM
    Pharmacol Biochem Behav; 1989 Apr; 32(4):939-43. PubMed ID: 2477864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties.
    Portoghese PS; Larson DL; Jiang JB; Caruso TP; Takemori AE
    J Med Chem; 1979 Feb; 22(2):168-73. PubMed ID: 218009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.
    Koman A; Kolb VM; Terenius L
    Pharm Res; 1987 Apr; 4(2):147-9. PubMed ID: 2855368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs.
    Huang B; Tang S; Desai A; Cheng XM; Kotlyar A; Van Der Spek A; Thomas TP; Baker JR
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5016-20. PubMed ID: 19632838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the influence of the opiate delta receptor antagonist, ICI 154,129, and naloxone on social interaction and behaviour in an open field.
    Benton D; Brain S; Brain PF
    Neuropharmacology; 1984 Jan; 23(1):13-7. PubMed ID: 6325983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone sensitive orphanin FQ-induced analgesia in mice.
    Rossi GC; Leventhal L; Pasternak GW
    Eur J Pharmacol; 1996 Sep; 311(2-3):R7-8. PubMed ID: 8891615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison in the mouse of the effect of the opiate delta receptor antagonist ICI 154129 and naloxone in tests of extinction, passive avoidance and food intake.
    Benton D; Dalrymple-Alford JC; McAllister KH; Brain PF; Brain S
    Psychopharmacology (Berl); 1984; 82(1-2):41-5. PubMed ID: 6320249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists.
    Lattin DL; Caviness B; Hudson RG; Greene DL; Raible PK; Richardson JB
    J Med Chem; 1981 Jul; 24(7):903-6. PubMed ID: 6268789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that opiate receptors mediate suppression of hypertonic saline-induced drinking in the mouse by narcotic antagonists.
    Brown DR; Holtzman SG
    Life Sci; 1980 May; 26(18):1543-50. PubMed ID: 6248713
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of hyperthermia-induced seizures in immature rats by a hydantoin derivative of naloxone.
    Chatterjie N; Laorden ML; Puig MM; Alexander GJ
    Life Sci; 1989; 45(10):857-62. PubMed ID: 2796585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the involvement of opioid receptors in the action of anticonvulsants.
    Jackson HC; Nutt DJ
    Psychopharmacology (Berl); 1993; 111(4):486-90. PubMed ID: 7870991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
    Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
    Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemistry of novel delta selective opiate antagonists.
    Kolb VM; Hua DH; Duax WL
    NIDA Res Monogr; 1986; 75():45-8. PubMed ID: 2828990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
    Shinohara A; Andoh T; Saiki I; Kuraishi Y
    Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.